Invasive mediastinal staging for non-small-cell lung cancer

Gastrointestinal Endoscopy

Volumn 67, Issue 2, 2008, Pages 199-201

  Martin, Linda W ^a  

^a St Joseph Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EDITORIAL; ENDOSCOPIC ECHOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; METASTASIS; MULTIMODALITY CANCER THERAPY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL ASPIRATION; TRANSTHORACIC ASPIRATION;

BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINOSCOPY; MEDIASTINUM; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 38349156158     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.09.001     Document Type: Editorial

References (16)

1. Lopez-Encuentra A., Garcia-Lujan R., Rivas J.J., et al. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 79 (2005) 974-979
2. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
3. Park B.J., Flores R., Downey R.J., et al. Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg 126 (2003) 726-731
4. Toloza E.M., Harpole L., Detterbeck F., et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 1 Suppl (2003) S157-S166
5. Eloubeidi M.A., Desmond R., Desai S., et al. Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer. Gastrointest Endosc 67 (2008) 193-198
6. Krasnik M. Endoscopic transesophageal and endoscopic transbronchial real-time ultrasound-guided biopsy. Respiration 70 (2003) 293-298
7. Eloubeidi M.A., Tamhane A., Chen V.K., et al. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. Ann Thorac Surg 80 (2005) 1231-1239
8. Cerfolio R.J., Bryant A.S., and Eloubeidi M.A. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 130 (2006) 1791-1795
9. Eloubeidi M.A., Cerfolio R.J., Chen V.K., et al. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg 79 (2005) 263-268
10. Bonferroni CE. II calcolo delle assicurazioni su gruppi di teste. In: Studi in Onore del Professore Salvatore Ortu Carboni. Rome: 1935. p. 13-60.
11. Meyers B.F., Downey R.J., Decker P.A., et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133 (2007) 738-745
12. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
13. Albain K.S., Swann R.S., Rusch V.R., et al. North American Lung Cancer Intergroup. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small-cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 23 (2005) 7014
14. Betticher D.C., Hsu Schmitz S.F., Totsch M., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
15. Bueno R., Richards W.G., Swanson S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
16. Jaklitsch M.T., Herndon J.E., Decamp M.M., et al. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. J Surg Oncol 94 (2006) 599-606